RCM-Focused Introduction
Medicare spending on ambulatory surgery center services jumped 15.9% in a single year — from 2023 to 2024 — reaching $7.5 billion in total FFS Medicare program spending and beneficiary cost sharing, according to the Medicare Payment Advisory Commission’s March 2026 report to Congress. The 2 fastest-growing ASC specialties driving that surge are pain management and cardiology — 2 of the core specialties Cosentus serves. For revenue cycle teams, explosive volume growth at this scale is not simply a positive headline: it brings compounding billing complexity, rising payer scrutiny, and mounting pressure on coding accuracy and collections workflows.
1. Revenue Cycle Impact: A 16% Spending Surge Signals a Volume Problem as Much as an Opportunity
From 2019 through 2023, Medicare ASC spending grew at an average annual rate of 9.4%. The jump to 15.9% growth in 2024 alone represents a sharp acceleration that caught MedPAC’s attention. The volume of ASC procedures per beneficiary rose 3.5% in 2024, compared to an average annual growth rate of just 1.3% from 2019–2023. For ASC billing teams, this trajectory means more claims, more coding decisions, and more payer interactions every month — all while denial rates and documentation requirements are simultaneously tightening across commercial and government payers. Practices that have not scaled their revenue cycle infrastructure proportionally to volume growth are likely leaving money on the table.
2. Revenue Cycle Impact: Pain Management and Cardiology Are the Fastest-Growing ASC Specialties
The MedPAC report identifies pain management and cardiology as the 2 fastest-growing ASC specialties from 2023 to 2024. Among multispecialty ASC facilities, pain management and orthopedics are the most common service lines. This concentration means that the revenue cycle challenges specific to these specialties — high prior authorization burdens, procedure-level coding complexity, payer-specific global period rules, and post-procedure denial patterns — are increasingly central to overall ASC financial performance. Pain management practices handling epidural steroid injections, nerve blocks, and spinal cord stimulator implants, and cardiology ASCs managing electrophysiology and PCI procedures, face the most complex billing environments in the outpatient setting.
3. Revenue Cycle Impact: Site-of-Care Migration Is Reshaping Coding and Payer Workflows
A significant portion of ASC volume growth is driven by procedures migrating from hospital outpatient departments (HOPDs) to the lower-cost ASC setting. While this migration reduces per-unit Medicare costs, it creates revenue cycle friction: commercial payers have historically been slower to align coverage policies with Medicare’s expanded ASC Covered Procedures List. Practices moving procedures to the ASC setting must build payer-specific authorization tracking for newly eligible codes, anticipate commercial payer denials on procedures Medicare now covers in ASCs, and update fee schedules to reflect ASC reimbursement rates rather than HOPD rates. Failing to manage these transitions at the claim level leads directly to underpayments and avoidable write-offs.
4. Revenue Cycle Impact: $7.5 Billion in Medicare ASC Spend Will Intensify Payer Scrutiny
At $7.5 billion in total Medicare ASC spending in 2024 and a 16% annual growth rate, ASCs are no longer a peripheral line item in Medicare’s budget. MedPAC directly noted that while ASC care lowers costs per procedure, increased service volume could offset the reduction in total Medicare spending — a statement that signals future payment pressure and tighter oversight is likely. Practices should expect more claim audits, more documentation requests, and more aggressive pre-payment review for high-volume ASC procedure codes. Revenue cycle teams that are not running proactive compliance checks and documentation audits now are building risk into their future collections.
5. Revenue Cycle Impact: Quality Reporting Alignment Creates a New Compliance Obligation
MedPAC recommended that CMS synchronize measures in the ASC Quality Reporting Program with the Hospital Outpatient Quality Reporting Program, enabling direct performance comparisons between ASCs and HOPDs. If CMS acts on this recommendation, ASCs will face new quality reporting obligations tied to the same metrics used to evaluate hospital outpatient departments — a significant operational and compliance shift. Revenue cycle teams must monitor these developments closely, as quality measure performance increasingly ties to payment adjustments, network inclusion decisions, and payer contract terms for high-volume ASC specialties.
What This Means for Specialty Practices
For pain management, cardiology, orthopedic, and multispecialty ASC practices, this MedPAC data represents both validation and warning. The sustained volume growth confirms that the ASC model is working — more patients, more procedures, more revenue opportunity. But a 16% spending surge in a single year draws direct regulatory attention, and MedPAC’s language on volume offsetting savings is an early signal of tighter payment policy ahead. Practices that treat this growth phase as business as usual risk entering a period of heightened scrutiny without the billing infrastructure to defend their revenue. The practices that will perform best through the next cycle of ASC payment policy are those that invest in coding accuracy, payer contract alignment, and denial prevention now — before oversight tightens.
How Cosentus Helps ASC and Specialty Practices Protect Revenue
Cosentus has partnered with specialty practices and ASCs for 25 years, combining real human expertise with AI-assisted analytics to build revenue cycle operations that scale with practice growth — not behind it. As ASC volume accelerates, the practices that protect their margins are the ones with the right infrastructure in place before payer scrutiny intensifies.
Our specialty ASC clients see revenue and collections growth of up to 30%, through services designed for exactly the challenges this growth cycle creates:
- Specialty-trained coding teams with deep expertise in pain management, cardiology, orthopedics, and ASC procedure coding — ensuring every claim reflects the full complexity of care delivered
- Proactive denial prevention that identifies authorization gaps, documentation risks, and coding errors before claims are submitted, not after they are denied
- Site-of-care transition support for practices migrating procedures from HOPD to ASC settings, including payer-specific coverage tracking and fee schedule recalibration
- Payer contract benchmarking and underpayment recovery to ensure ASC reimbursement rates reflect current market conditions and that short-paid claims are identified and pursued
- Compliance monitoring and quality reporting readiness to help practices stay ahead of evolving CMS and payer documentation requirements before they affect payment
- Real-time analytics and procedure-level reporting that give ASC leadership clear visibility into payer performance, denial trends, and collection rates by service line
ASC volume growth is an opportunity. Whether it becomes a revenue gain or a compliance liability depends entirely on the strength of the revenue cycle operation behind it.
